Adicet Bio ACET
NASDAQ ACET
$9.25 -0.13 (-1.39%)
As of: Aug 21, 2026 · 11:23 AM EDT

Adicet Bio (ACET) Deferred Taxes (2019 - 2020)

Adicet Bio (ACET) posted quarterly Deferred Taxes of $519000.0 for Q4 2020, up 1502.7% year-over-year from $32382.8 in Q1 2020, and up 1721.88% quarter-over-quarter from -$32000.0 in Q3 2020.

Adicet Bio (ACET) Deferred Taxes (2019 - 2020) Analysis & Trends

Adicet Bio's Deferred Taxes history runs 2 years deep, the most recent figure standing at $519000.0 for Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Vertex Pharmaceuticals 139.84 Bn 131.99 Bn 2.84 Bn -69.70 Mn
2 Regeneron Pharmaceuticals 86.48 Bn 78.49 Bn 3.93 Bn 194.40 Mn
3 Argenx Se 65.47 Bn 60.29 Bn 1.37 Bn -
4 Moderna 60.15 Bn 55.01 Bn 52.00 Mn -
5 BeOne Medicines 42.22 Bn 37.12 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.67 Bn 28.36 Bn 992.69 Mn 2.66 Mn
7 BioNTech SE 28.54 Bn 10.14 Bn 668.28 Mn -
8 Insmed 27.58 Bn 26.42 Bn 358.27 Mn -
9 Royalty Pharma 27.22 Bn 26.38 Bn - -
10 Adicet Bio 99.40 Mn -18.79 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2020 519,000.00
Sep 30, 2020 -32,000.00
Dec 31, 2019 -37,000.00